Cognitive-psychophysiological Treatment for Tics in Young People With Tourette's Syndrome
The goal of this clinical trial is to compare the effectiveness of CoPs therapy with or without the therapeutic component of biofeedback in treating tics in Tourette Syndrome with emerging young adults. Hypotheses: 1. The CoPs+Biofeedback treatment will improve the severity of tics (YGTSS) and the Clinical Global Impre
| Condition(s) | Tourette Syndrome, Tics, Tourette Syndrome in Adolescence |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to compare the effectiveness of CoPs therapy with or without the therapeutic component of biofeedback in treating tics in Tourette Syndrome with emerging young adults. Hypotheses: 1. The CoPs+Biofeedback treatment will improve the severity of tics (YGTSS) and the Clinical Global Impression, surpassing the clinical significance threshold of CoPs treatment alone. 2. We expect that the identified variables (psychosocial, neurocognitive, biological) will predict the improvement of tics. Researchers will compare if the biofeedback treatment will improve the severity of tics. * In the pre-test, participants will undergo two interviews, each lasting 3 hours. These interviews will assess (through a battery of tests) the severity of tics as well as the psychosocia |
| Who can participate | Inclusion Criteria: * Have a diagnosis of TS or to experience bothersome tics; * Be aged 14 to 21 years inclusive at the start of therapy. Exclusion Criteria: * Present a sensorimotor impairment; * Have a diagnosis of intellectual disability (intelligence quotient below 75); * Alcohol or drug abuse; * A neurological issue (e.g., hemifacial spasms, Huntington's disease); * Change medication one month or less before step 1 and up to step 4 (last measurement time) without informing a member of the research team; * Simultaneously receive another intervention for tics (e.g., psychologist, massage therapist) without informing a research team member. |
| Ages | 14 Years to 21 Years |
| Sex | All |
| Lead sponsor | Université du Québec a Montréal |
| Locations | Montreal, Quebec, Canada |
| Start date | 2025-04-15 |
| NCT ID | NCT06873841 |
| Official listing | https://clinicaltrials.gov/study/NCT06873841 |